{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:36:41Z","timestamp":1780976201297,"version":"3.54.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/adm.0b013e318262a97a","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T10:28:58Z","timestamp":1342607338000},"page":"280-286","source":"Crossref","is-referenced-by-count":27,"title":["Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders"],"prefix":"10.1097","volume":"6","author":[{"given":"Hannah K.","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/biomet\/86.4.948","article-title":"Small sample degrees of freedom with multiple imputation.","volume":"86","author":"Barnard","year":"1999","journal-title":"Biometrika"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/01615440.1995.9956360","article-title":"Analyzing historical count data: Poisson and negative binomial regression models.","volume":"28","author":"Beck","year":"1995","journal-title":"Hist Methods"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1377\/hlthaff.2011.0480","article-title":"The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.","volume":"30","author":"Buck","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0168-8510(03)00066-6","article-title":"The economics of public health: financing drug abuse treatment services.","volume":"66","author":"Cartwright","year":"2003","journal-title":"Health Policy"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: improving public health and safety.","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-3-17","article-title":"State policy influence on the early diffusion of buprenorphine in community treatment programs.","volume":"3","author":"Ducharme","year":"2008","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2006.05.021","article-title":"Innovation adoption in substance abuse treatment: exposure, trial ability, and the Clinical Trials Network.","volume":"32","author":"Ducharme","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): availability, barriers, and intentions.","volume":"33","author":"Friedmann","year":"2012","journal-title":"Subst Abus"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11414-009-9169-z","article-title":"Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs.","volume":"37","author":"Friedmann","year":"2010","journal-title":"J Behav Health Serv Res"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ps.2010.61.11.1081","article-title":"Health reform and the scope of benefits for mental health and substance use disorder services.","volume":"61","author":"Garfield","year":"2010","journal-title":"Psychiatr Serv"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jsat.2008.08.004","article-title":"Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review.","volume":"36","author":"Garner","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0740-5472(02)00269-6","article-title":"Putting drug abuse research to use in real-life settings.","volume":"23","author":"Hanson","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1475-6773.2007.00812.x","article-title":"Role of state policies in the adoption of naltrexone for substance abuse treatment.","volume":"43","author":"Heinrich","year":"2008","journal-title":"Health Serv Res"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0376-8716(03)00055-3","article-title":"From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.","volume":"70","author":"Jaffe","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.","volume":"34","author":"Knudsen","year":"2011","journal-title":"Eval Program Plann"},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs.","volume":"5","author":"Knudsen","year":"2011","journal-title":"J Addict Med"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jsat.2006.03.013","article-title":"Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors.","volume":"30","author":"Knudsen","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"R21-7-20210126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2006.08.013","article-title":"The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.","volume":"87","author":"Knudsen","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0b013e3181b41a32","article-title":"Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations.","volume":"4","author":"Knudsen","year":"2010","journal-title":"J Addict Med"},{"key":"R23-7-20210126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2005.12.005","article-title":"Characteristics of US substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.","volume":"83","author":"Koch","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R24-7-20210126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jsat.2008.08.009","article-title":"Departments of corrections as purchasers of community-based treatment: a national study.","volume":"36","author":"Kubiak","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"R26-7-20210126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0740-5472(02)00257-X","article-title":"Buprenorphine: blending practice and research.","volume":"23","author":"Ling","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R30-7-20210126","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R31-7-20210126","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(03)00134-0","article-title":"Understanding US addiction physicians low rate of naltrexone prescription.","volume":"71","author":"Mark","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R32-7-20210126","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1177\/0032885511415223","article-title":"Evidence-based policies and practices for drug-involved offenders.","volume":"91","author":"Marlowe","year":"2011","journal-title":"Prison J"},{"key":"R33-7-20210126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2007.08.004","article-title":"Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.","volume":"92","author":"McCarty","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R35-7-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R37-7-20210126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jurban\/jti072","article-title":"Attitudes and practices regarding the use of methadone in US state and federal prisons.","volume":"82","author":"Rich","year":"2005","journal-title":"J Urban Health"},{"key":"R39-7-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11414-008-9122-6","article-title":"Implementation of evidence-based practices for treatment of alcohol and drug disorders: the role of the state authority.","volume":"36","author":"Rieckmann","year":"2009","journal-title":"J Behav Health Serv Res"},{"key":"R40-7-20210126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.addbeh.2011.01.032","article-title":"Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.","volume":"36","author":"Roman","year":"2011","journal-title":"Addict Behav"},{"key":"R41-7-20210126","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jsat.2009.12.008","article-title":"A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.","volume":"38","author":"Roman","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"R42-7-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1536867X0400400301","article-title":"Multiple imputation of missing values.","volume":"4","author":"Royston","year":"2004","journal-title":"Stata J"},{"key":"R43-7-20210126","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1536867X0500500204","article-title":"Multiple imputation of missing values: update.","volume":"5","author":"Royston","year":"2005","journal-title":"Stata J"},{"key":"R44-7-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1536867X0500500404","article-title":"Multiple imputation of missing values: update of ice.","volume":"5","author":"Royston","year":"2005","journal-title":"Stata J"},{"key":"R46-7-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2011.06.009","article-title":"Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.","volume":"42","author":"Savage","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"R47-7-20210126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2005.06.014","article-title":"Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs.","volume":"108","author":"Saxon","year":"2005","journal-title":"Pharmacol Ther"},{"key":"R48-7-20210126","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/002204260403400210","article-title":"Review of corrections-based therapy for opiate-dependent patients: implications for buprenorphine treatment among correctional populations.","volume":"34","author":"Smith-Rohrberg","year":"2004","journal-title":"J Drug Issues"},{"key":"R49-7-20210126","first-page":"389","article-title":"Health services and financing of treatment.","volume":"33","author":"Stewart","year":"2011","journal-title":"Alcohol Res Health"},{"key":"R50-7-20210126","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1475-6773.2010.01206.x","article-title":"Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.","volume":"46","author":"Terry-McElrath","year":"2011","journal-title":"Health Serv Res"},{"key":"R51-7-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2010.08.005","article-title":"Advancing performance measure for use of medications in substance abuse treatment.","volume":"40","author":"Thomas","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"R52-7-20210126","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/ps.2008.59.8.909","article-title":"Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists.","volume":"59","author":"Thomas","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R53-7-20210126","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11414-008-9132-4","article-title":"Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication.","volume":"37","author":"Wallack","year":"2010","journal-title":"J Behav Health Serv Res"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ADM.0b013e318262a97a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:08:10Z","timestamp":1620943690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-201212000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e318262a97a","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}